Cita APA

Duggan, B. M., Foley, K. P., Henriksbo, B. D., Cavallari, J. F., Tamrakar, A. K., & Schertzer, J. D. (2017). Tyrosine kinase inhibitors of Ripk2 attenuate bacterial cell wall-mediated lipolysis, inflammation and dysglycemia. Sci Rep.

Chicago Style Citation

Duggan, Brittany M., Kevin P. Foley, Brandyn D. Henriksbo, Joseph F. Cavallari, Akhilesh K. Tamrakar, i Jonathan D. Schertzer. "Tyrosine Kinase Inhibitors of Ripk2 Attenuate Bacterial Cell Wall-mediated Lipolysis, Inflammation and Dysglycemia." Sci Rep 2017.

Cita MLA

Duggan, Brittany M., et al. "Tyrosine Kinase Inhibitors of Ripk2 Attenuate Bacterial Cell Wall-mediated Lipolysis, Inflammation and Dysglycemia." Sci Rep 2017.